Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

ELEctroconvulsive therapy (ECT) vs. Ketamine in patients with Treatment-resistant Depression: The ELEKT-D study protocol.

Mathew SJ, Wilkinson ST, Altinay M, Asghar-Ali A, Chang LC, Collins KA, Dale RM, Hu B, Krishnan K, Kellner CH, Malone DA, Murrough JW, Ostroff RB, Sanacora G, Shao M, Anand A.

Contemp Clin Trials. 2019 Feb;77:19-26. doi: 10.1016/j.cct.2018.12.009. Epub 2018 Dec 17.

PMID:
30572160
2.

Closing the Loop on Deep Brain Stimulation for Treatment-Resistant Depression.

Widge AS, Malone DA Jr, Dougherty DD.

Front Neurosci. 2018 Mar 21;12:175. doi: 10.3389/fnins.2018.00175. eCollection 2018. Review.

3.

Deep brain stimulation of the ventral striatal area for poststroke pain syndrome: a magnetoencephalography study.

Gopalakrishnan R, Burgess RC, Malone DA, Lempka SF, Gale JT, Floden DP, Baker KB, Machado AG.

J Neurophysiol. 2018 Jun 1;119(6):2118-2128. doi: 10.1152/jn.00830.2017. Epub 2018 Jan 31.

4.

Randomized clinical trial of deep brain stimulation for poststroke pain.

Lempka SF, Malone DA Jr, Hu B, Baker KB, Wyant A, Ozinga JG 4th, Plow EB, Pandya M, Kubu CS, Ford PJ, Machado AG.

Ann Neurol. 2017 May;81(5):653-663. doi: 10.1002/ana.24927.

PMID:
28380672
5.

Cognitive outcome after ventral capsule/ventral striatum stimulation for treatment-resistant major depression.

Kubu CS, Brelje T, Butters MA, Deckersbach T, Malloy P, Moberg P, Tröster AI, Williamson E, Baltuch GH, Bhati MT, Carpenter LL, Dougherty DD, Howland RH, Rezai AR, Malone DA Jr.

J Neurol Neurosurg Psychiatry. 2017 Mar;88(3):262-265. doi: 10.1136/jnnp-2016-313803. Epub 2016 Sep 22.

PMID:
27659923
6.

A Randomized Sham-Controlled Trial of Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Chronic Treatment-Resistant Depression.

Dougherty DD, Rezai AR, Carpenter LL, Howland RH, Bhati MT, O'Reardon JP, Eskandar EN, Baltuch GH, Machado AD, Kondziolka D, Cusin C, Evans KC, Price LH, Jacobs K, Pandya M, Denko T, Tyrka AR, Brelje T, Deckersbach T, Kubu C, Malone DA Jr.

Biol Psychiatry. 2015 Aug 15;78(4):240-8. doi: 10.1016/j.biopsych.2014.11.023. Epub 2014 Dec 13.

PMID:
25726497
7.

A comprehensive review of the use of deep brain stimulation (DBS) in treatment of psychiatric and headache disorders.

Altinay M, Estemalik E, Malone DA Jr.

Headache. 2015 Feb;55(2):345-50. doi: 10.1111/head.12517. Epub 2015 Feb 6. Review.

PMID:
25660121
8.

Neuropsychological outcome after deep brain stimulation in the ventral capsule/ventral striatum for highly refractory obsessive-compulsive disorder or major depression.

Kubu CS, Malone DA, Chelune G, Malloy P, Rezai AR, Frazier T, Machado A, Rasmussen S, Friehs G, Greenberg BD.

Stereotact Funct Neurosurg. 2013;91(6):374-8. doi: 10.1159/000348321. Epub 2013 Oct 9.

PMID:
24108099
9.

A practical approach to prescribing antidepressants.

Shultz E, Malone DA Jr.

Cleve Clin J Med. 2013 Oct;80(10):625-31. doi: 10.3949/ccjm.80a.12133.

PMID:
24085807
11.

Deep brain stimulation for treatment-resistant depression.

Taghva AS, Malone DA, Rezai AR.

World Neurosurg. 2013 Sep-Oct;80(3-4):S27.e17-24. doi: 10.1016/j.wneu.2012.10.068. Epub 2012 Oct 27. Review.

PMID:
23111230
12.

Cerebral stimulation for the affective component of neuropathic pain.

Machado AG, Baker KB, Plow E, Malone DA.

Neuromodulation. 2013 Nov-Dec;16(6):514-8. doi: 10.1111/j.1525-1403.2012.00517.x. Epub 2012 Oct 24. Review.

13.

Where in the brain is depression?

Pandya M, Altinay M, Malone DA Jr, Anand A.

Curr Psychiatry Rep. 2012 Dec;14(6):634-42. doi: 10.1007/s11920-012-0322-7. Review.

14.

Effects of electroconvulsive therapy on brain functional activation and connectivity in depression.

Beall EB, Malone DA, Dale RM, Muzina DJ, Koenig KA, Bhattacharrya PK, Jones SE, Phillips MD, Lowe MJ.

J ECT. 2012 Dec;28(4):234-41. doi: 10.1097/YCT.0b013e31825ebcc7.

PMID:
22820953
15.

Axonal pathways linked to therapeutic and nontherapeutic outcomes during psychiatric deep brain stimulation.

Lujan JL, Chaturvedi A, Malone DA, Rezai AR, Machado AG, McIntyre CC.

Hum Brain Mapp. 2012 Apr;33(4):958-68. doi: 10.1002/hbm.21262. Epub 2011 Apr 21.

16.

Rate of non-adherence prior to upward dose titration in previously stable antidepressant users.

Muzina DJ, Malone DA, Bhandari I, Lulic R, Baudisch R, Keene M.

J Affect Disord. 2011 Apr;130(1-2):46-52. doi: 10.1016/j.jad.2010.09.018. Epub 2010 Oct 14.

PMID:
20950862
17.

Use of deep brain stimulation in treatment-resistant depression.

Malone DA Jr.

Cleve Clin J Med. 2010 Jul;77 Suppl 3:S77-80. doi: 10.3949/ccjm.77.s3.14. Review.

PMID:
20622083
18.
19.

Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression.

Malone DA Jr, Dougherty DD, Rezai AR, Carpenter LL, Friehs GM, Eskandar EN, Rauch SL, Rasmussen SA, Machado AG, Kubu CS, Tyrka AR, Price LH, Stypulkowski PH, Giftakis JE, Rise MT, Malloy PF, Salloway SP, Greenberg BD.

Biol Psychiatry. 2009 Feb 15;65(4):267-75. doi: 10.1016/j.biopsych.2008.08.029. Epub 2008 Oct 8.

20.

Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience.

Greenberg BD, Gabriels LA, Malone DA Jr, Rezai AR, Friehs GM, Okun MS, Shapira NA, Foote KD, Cosyns PR, Kubu CS, Malloy PF, Salloway SP, Giftakis JE, Rise MT, Machado AG, Baker KB, Stypulkowski PH, Goodman WK, Rasmussen SA, Nuttin BJ.

Mol Psychiatry. 2010 Jan;15(1):64-79. doi: 10.1038/mp.2008.55. Epub 2008 May 20.

21.

Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder.

Greenberg BD, Malone DA, Friehs GM, Rezai AR, Kubu CS, Malloy PF, Salloway SP, Okun MS, Goodman WK, Rasmussen SA.

Neuropsychopharmacology. 2006 Nov;31(11):2384-93. Epub 2006 Jul 19. Erratum in: Neuropsychopharmacology. 2006 Nov;31(11):2394.

22.

Side effects of antidepressants: an overview.

Khawam EA, Laurencic G, Malone DA Jr.

Cleve Clin J Med. 2006 Apr;73(4):351-3, 356-61. Review.

PMID:
16610395
23.

Behavioral neurosurgery.

Malone DA Jr, Pandya MM.

Adv Neurol. 2006;99:241-7. Review. No abstract available.

PMID:
16536372
24.

Should amphetamines be added to SSRI therapy to enhance the antidepressant effect?

Singh V, Malone DA Jr.

Cleve Clin J Med. 2001 Sep;68(9):748-9. Review. No abstract available.

PMID:
11563476
25.

Panic disorder in primary care: a cause of unexplained symptoms.

Muzina DJ, Malone DA.

Cleve Clin J Med. 1997 Sep;64(8):437-43. Review.

PMID:
9308220
26.

New antidepressants: more options for tailoring treatment.

Muzina DJ, Malone DA Jr.

Cleve Clin J Med. 1996 Nov-Dec;63(7):406-12; quiz 420. Review.

PMID:
8961619
27.

Psychiatric effects and psychoactive substance use in anabolic-androgenic steroid users.

Malone DA Jr, Dimeff RJ, Lombardo JA, Sample RH.

Clin J Sport Med. 1995;5(1):25-31.

PMID:
7614077
28.

The use of fluoxetine in depression associated with anabolic steroid withdrawal: a case series.

Malone DA Jr, Dimeff RJ.

J Clin Psychiatry. 1992 Apr;53(4):130-2.

PMID:
1564048
29.

Ophthalmologic effects of psychotropic medications.

Malone DA Jr, Camara EG, Krug JH Jr.

Psychosomatics. 1992 Summer;33(3):271-7. Review.

PMID:
1410200
30.

Tone discrimination secondary to amitriptyline.

Malone DA Jr.

J Clin Psychopharmacol. 1991 Jun;11(3):221-2. No abstract available.

PMID:
2066463
31.

Treatment of psychotic symptoms in OCD patients.

Deckert DW, Malone DA Jr.

J Clin Psychiatry. 1990 Jun;51(6):259. No abstract available.

PMID:
1971824
32.

Successful treatment of acquired Tourettism and major depression.

Malone DA Jr, Stern TA.

J Geriatr Psychiatry Neurol. 1988 Jul-Sep;1(3):169-71.

PMID:
3252884
33.

Blunting of TSH response to TRH in chronic cocaine and phencyclidine abusers.

Giannini AJ, Malone DA, Loiselle RH, Price WA.

J Clin Psychiatry. 1987 Jan;48(1):25-6.

PMID:
3100509
34.

Enterococcal bacteremia in two large community teaching hospitals.

Malone DA, Wagner RA, Myers JP, Watanakunakorn C.

Am J Med. 1986 Oct;81(4):601-6.

PMID:
3766590
35.

Treatment of depression in chronic cocaine and phencyclidine abuse with desipramine.

Giannini AJ, Malone DA, Giannini MC, Price WA, Loiselle RH.

J Clin Pharmacol. 1986 Mar;26(3):211-4.

PMID:
3514688
36.

The serotonin irritation syndrome--a new clinical entity?

Giannini AJ, Malone DA, Piotrowski TA.

J Clin Psychiatry. 1986 Jan;47(1):22-5. Review.

PMID:
2416736
37.

Comparison of chlorpromazine, haloperidol and pimozide in the treatment of phencyclidine psychosis: DA-2 receptor specificity.

Giannini AJ, Nageotte C, Loiselle RH, Malone DA, Price WA.

J Toxicol Clin Toxicol. 1984-1985;22(6):573-9.

PMID:
6535849

Supplemental Content

Loading ...
Support Center